Literature DB >> 15134361

Metabolism of daidzein by intestinal bacteria from rhesus monkeys (Macaca mulatta).

Fatemeh Rafii1, Charlotte Hotchkiss, Thomas M Heinze, Miseon Park.   

Abstract

PURPOSE: To identify the metabolites produced from an isoflavonoid, daidzein, by colonic bacteria of rhesus monkeys.
METHODS: The metabolism of daidzein by the fecal bacteria of nine monkeys was investigated. Daidzein was incubated anaerobically with fecal bacteria, and the metabolites were analyzed by use of liquid chromatography and mass spectrometry.
RESULTS: The fecal bacteria of all of the monkeys metabolized daidzein to various extents. Dihydrodaidzein was found in cultures of fecal bacteria from two monkeys; dihydrodaidzein and equol were found in cultures from four monkeys; dihydrodaidzein, equol, and an unknown metabolite (MW = 244) were found in cultures from one monkey; and dihydrodaidzein and the unknown metabolite were found in cultures from two monkeys.
CONCLUSIONS: Similar to that in humans, variation was evident in the metabolism of isoflavonoids by fecal bacteria from rhesus monkeys. Some metabolites produced by fecal bacteria from monkeys were the same as those produced by fecal bacteria from humans.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15134361

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  3 in total

1.  Comparison of the effects of antimicrobial agents from three different classes on metabolism of isoflavonoids by colonic microflora using Etest strips.

Authors:  John B Sutherland; Brad M Bridges; Thomas M Heinze; Michael R Adams; Patrick J Delio; Charlotte Hotchkiss; Fatemeh Rafii
Journal:  Curr Microbiol       Date:  2011-10-18       Impact factor: 2.188

Review 2.  Does equol production determine soy endocrine effects?

Authors:  Dana Shor; Thozhukat Sathyapalan; Stephen L Atkin; Natalie J Thatcher
Journal:  Eur J Nutr       Date:  2012-02-25       Impact factor: 5.614

3.  Stereospecific biotransformation of dihydrodaidzein into (3S)-equol by the human intestinal bacterium Eggerthella strain Julong 732.

Authors:  Mihyang Kim; Su-Il Kim; Jaehong Han; Xiu-Ling Wang; Dae-Geun Song; Soo-Un Kim
Journal:  Appl Environ Microbiol       Date:  2009-03-20       Impact factor: 4.792

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.